Saúde Pública/Medicina Humanitária
Estudo mostra alta efetividade da vacina de mRNA da Pfizer contra a COVID-19 na gestação.
8 Set, 2021 | 15:22hEffectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy – Nature Medicine
Comentários no Twitter
NEW: Estimated vaccine effectiveness in #pregnancy from 7 through to 56 d after second dose was 96% (95% CI; 89–100%) for any documented infection, 97% (91–100%) for infections with documented symptoms & 89% (43–100%) for #COVID19-related hospitalization. https://t.co/bm950wUWGL
— All Source Pregnancy (@PregnancyAll) September 7, 2021
The Pfizer-BioNTech mRNA COVID-19 vaccine was estimated to have high vaccine effectiveness in pregnant women, which is similar to the effectiveness estimated in the general population, according to a @NatureMedicine paper. https://t.co/oz5zn7zNdq pic.twitter.com/9IP5ocxzXs
— Nature Portfolio (@NaturePortfolio) September 7, 2021
Chile autoriza o uso da vacina da Sinovac para crianças de 6 anos de idade ou mais.
8 Set, 2021 | 15:19hChile authorizes Sinovac vaccine for kids of 6 and older – Associated Press
Novas recomendações da AAP sobre gripe autorizam que seja coadministrada com a vacina contra COVID-19.
8 Set, 2021 | 15:16hComunicado de imprensa: AAP flu recommendations allow for coadministration with COVID-19 vaccine – American Academy of Pediatrics
Relatório técnico: Recommendations for Prevention and Control of Influenza in Children, 2021–2022 – American Academy of Pediatrics
Conteúdo relacionado: New CDC Guidance says influenza and Covid vaccines can be given together – “COVID-19 vaccines and other vaccines may now be administered without regard to timing”
Comentário no Twitter
The 2021-’22 @AmerAcadPeds flu policy emphasizes the importance of flu vaccination during the SARS-CoV-2 pandemic, allows for coadministration with COVID-19 vaccine. https://t.co/usLaO276Ku pic.twitter.com/EaL5vocxMm
— AAP News (@AAPNews) September 7, 2021
Intervalos maiores entre as doses e doses de reforço da vacina da AstraZeneca estão associados com aumento da imunogenicidade.
7 Set, 2021 | 22:13hComentário convidado: Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine
Comentários no Twitter
(fio – clique para saber mais)
Substudy suggests extended interval (up to 45 wks) before 2nd dose of ChAdOx1 nCoV-19 leads to increased antibody titres, offering more flexibility in vaccine schedules.
Extended interval before 3rd dose resulted in further increase in immune responses. https://t.co/J3xOwSSYMN pic.twitter.com/8GotDI4ctS
— The Lancet (@TheLancet) September 2, 2021
(fio – clique para saber mais)
New @TheLancet
The heightened immune response to longer spacing @AstraZeneca 1st -> 2nd vaccine doses and the response 3rd booster dose, with high neutralizing antibodies and T cellshttps://t.co/A2UcPVIFYP pic.twitter.com/zfYaW0T8Yf— Eric Topol (@EricTopol) September 1, 2021
[Preprint] Amplo estudo de coorte no Brasil mostrou que a vacina da AstraZeneca teve uma alta eficácia geral contra doença grave em indivíduos até 89 anos de idade. Em comparação, a vacina CoronaVac teve alta eficácia geral contra doença grave em indivíduos até 79 anos de idade.
7 Set, 2021 | 22:11hRelatório CDC | Taxas de hospitalização por Covid-19 foram 10 vezes mais altas entre adolescentes não vacinados do que entre os vacinados.
7 Set, 2021 | 22:09hComentários:
More kids hospitalized with Covid-19 in states with lower vaccination rates, CDC report finds – CNN
Child COVID hospital cases up in low-vaccination states – CIDRAP
Comentário no Twitter
From late June to mid-August, there was a 10x increase in the rate of hospitalizations among children ages 0-4 with #COVID19 while the #DeltaVariant was widely circulating. It is critical for children to #maskup and get vaccinated if eligible. Learn more: https://t.co/aHC1vYdKVG. pic.twitter.com/uUeNPG6d5r
— CDC (@CDCgov) September 3, 2021
[Ainda não publicado] Dose de reforço da Sinovac reverte a queda da atividade dos anticorpos contra a variante Delta em estudo.
7 Set, 2021 | 22:05hSinovac booster shot reverses drop in antibody activities against Delta-study – Reuters
Comentário no Twitter
A booster dose of Sinovac Biotech's COVID-19 vaccine reversed a decline in antibody activities against the Delta variant, a study showed, easing some concerns about its longer-term immune response to the highly contagious strain of the virus. https://t.co/QdmMYVBrvl
— Reuters Health (@Reuters_Health) September 6, 2021
Opinião | Vídeo: imunidade é o único caminho para atravessar uma pandemia (com Dra. Monica Gandhi).
7 Set, 2021 | 22:04hImmunity Is The Only Way Through A Pandemic (w/Dr. Monica Gandhi) – ZDoggMD
Mais dados mostram o risco aumentado de hospitalização pela variante Delta do SARS-CoV-2.
6 Set, 2021 | 16:36hHospitalisation associated with SARS-CoV-2 delta variant in Denmark – The Lancet Infectious Diseases
Estudo relacionado: Cohort study: Patients with Covid-19 infected with the Delta variant are twice as likely to need hospital admission or emergency care attendance.
O ressurgimento de infecção por SARS-CoV-2 em um sistema de saúde com altas taxas de vacinação: a eficácia da vacina contra a infecção foi reduzida de 90% entre março e junho para 65% em julho.
6 Set, 2021 | 16:33hConteúdos relacionados:
Another study shows Pfizer mRNA vaccine immunity is reduced over time.
Comentário no Twitter (fio – clique para saber mais)
💥 NEW DATA💥
1/ "Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce" published today in @NEJM details ↓ in vaccine effectiveness against INFECTION among @UCSDHealth employees – from 95%+ in the spring to 65% in July
👉🏽 https://t.co/wMgjoLgJzS pic.twitter.com/lgOwlEqUQG
— Christopher A. Longhurst (@calonghurst) September 1, 2021